T. Kitazawa et al., In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for oestrone-3-sulphate across the blood-cerebrospinal fluid barrier, J PHARM PHA, 52(3), 2000, pp. 281-288
The efflux transport of oestrone-3-sulphate, a steroid hormone sulphate, ac
ross the blood-cerebrospinal fluid barrier has been examined following its
intracerebroventricular administration. [H-3]Oestrone-3-sulphate was elimin
ated from cerebrospinal fluid (CSF) with an apparent efflux clearance of 20
5 mu L min(-1) per rat. There was 25% of unmetabolized [H-3]oestrone-3-sulp
hate in the plasma 5 min after intracerebroventricular administration, indi
cating that at least a part of [H-3]oestrone-3-sulphate is transported from
CSF to the circulating blood across the blood-CSF barrier. This efflux tra
nsport was inhibited by co-administration of excess oestrone-3-sulphate (25
mM10 mu L =0.25 mu mol) into rat cerebral ventricle.
To characterize the oestrone-3-sulphate transport process, an in-vitro upta
ke experiment was performed using isolated rat choroid plexus. Oestrone-3-s
ulphate uptake by isolated rat choroid plexus was found to be a saturable p
rocess with a Michaelis-Menten constant (K-m) of 18.1 +/- 6.3 mu M, and a m
aximum uptake rate (V-max) of 48.0 +/- 15.1 pmol min(-1) mu L-1 of tissue.
The oestrone-3-sulphate transport process was temperature dependent and was
inhibited by metabolic inhibitors such as 2,4-dinitrophenol and rotenone,
suggesting an energy dependence. This uptake process was also inhibited by
steroid hormone sulphates (1 mM dehydroepiandrosterone sulphate and 1 mM oe
strone sulphate), bile acids (1 mM taurocholic acid and 1 mM cholic acid) a
nd organic anions (1 mM sulphobromophthalein and 1 mM phenolsulphonphthalei
n), whereas 1 mM p-aminohippuric acid, 1 mM p-nitrophenol sulphate, 0.1 mM
methotrexate and the cardiac glycoside, 2.5 mu M digoxin, had little effect
.
In conclusion, these results provide evidence that oestrone-3-sulphate is t
ransported from CSF to the circulating blood across the blood-CSF barrier v
ia a carrier-mediated efflux transport system.